DeLucia David 4

What Happened

• David DeLucia, Chief Financial Officer of Kyntra Bio, had 60 shares withheld by the company to satisfy a tax obligation arising from the vesting of restricted stock units. The withholding is reported as a disposition at $6.84 per share, totaling $410.

Key Details

• Transaction date: 2026-03-06
• Price: $6.84 per share; 60 shares; total disposition value $410
• Transaction code: F — shares withheld to satisfy tax liability
• Footnote: F1 — issuer withheld shares to satisfy the reporting person's tax obligation upon RSU vesting
• Filing date / Period of report: filed 2026-03-10; period of report 2026-03-06
• Shares owned after transaction: not specified in the provided filing excerpt
• Filing timeliness: the excerpt does not indicate a late-filing flag; check the full SEC filing for timeliness status

Context

• This was a tax-withholding event related to RSU vesting, not an open-market sale or purchase. Such withholdings are routine and generally do not indicate a change in the insider’s view of the company.